Cargando…
IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer
Elevated levels of IL-10 in the microenvironment of human ovarian cancer and murine models of ovarian cancer are well established and correlate with poor clinical prognosis. However, amongst a myriad of immunosuppressive factors, the actual contribution of IL-10 to the ovarian tumor microenvironment...
Autores principales: | Hart, Kevin M., Byrne, Katelyn T., Molloy, Michael J., Usherwood, Edward M., Berwin, Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342001/ https://www.ncbi.nlm.nih.gov/pubmed/22566819 http://dx.doi.org/10.3389/fimmu.2011.00029 |
Ejemplares similares
-
CX(3)CR1 Delineates Temporally and Functionally Distinct Subsets of Myeloid-Derived Suppressor Cells in a Mouse Model of Ovarian Cancer
por: Hart, Kevin M., et al.
Publicado: (2014) -
Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4(+) T cells
por: Thelen, Benedikt, et al.
Publicado: (2023) -
Innate Immunomodulation in Food Animals: Evidence for Trained Immunity?
por: Byrne, Kristen A., et al.
Publicado: (2020) -
Progesterone promotes immunomodulation and tumor development in the murine mammary gland
por: Werner, Lauryn R, et al.
Publicado: (2021) -
The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke
por: Gervois, Pascal, et al.
Publicado: (2019)